Breaking News

Lonza Expands Singapore Bioservices

Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore. Lonza’s Development Services business provides customized services for the development of robust biomanufacturing processes. The expansion will add 1,858 m² of lab space and associated equipment, and will support cell line construction, upstream and downstream process development, and a broad range of analytical services. Lonza currently offers these services in its Slough, UK facility with ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters